Cargando…
The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease
Background Vorapaxar has been shown to reduce cardiovascular mortality in post-myocardial infarction (MI) patients. Pharmacodynamic biomarker research related to protease-activated receptor-1 (PAR-1) inhibition with vorapaxar in humans has short follow-up (FU) duration and is mainly focused on plat...
Autores principales: | Nilsen, Dennis W. T., Røysland, Michelle, Ueland, Thor, Aukrust, Pål, Michelsen, Annika E., Staines, Harry, Barvik, Ståle, Kontny, Frederic, Nordrehaug, Jan Erik, Bonarjee, Vernon V. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113036/ https://www.ncbi.nlm.nih.gov/pubmed/36588289 http://dx.doi.org/10.1055/s-0042-1760256 |
Ejemplares similares
-
Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
por: Andersen, Thomas, et al.
Publicado: (2023) -
Podocan and Adverse Clinical Outcome in Patients Admitted With Suspected Acute Coronary Syndromes
por: Andersen, Thomas, et al.
Publicado: (2022) -
Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease
por: Olie, Renske H., et al.
Publicado: (2019) -
Complement component 7 is associated with total- and cardiac death in chest-pain patients with suspected acute coronary syndrome
por: Aarsetøy, Reidun, et al.
Publicado: (2021) -
The activity of pregnancy-associated plasma protein A (PAPP-A) as expressed by immunohistochemistry in atherothrombotic plaques obtained by aspiration thrombectomy in patients presenting with a ST-elevation myocardial infarction: a brief communication
por: Brügger-Andersen, Trygve, et al.
Publicado: (2010)